Evidence map›Paper›PMID 28401488›Full record

ArticleJournal of assisted reproduction and genetics2017

A no-stop mutation in MAGEB4 is a possible cause of rare X-linked azoospermia and oligozoospermia in a consanguineous Turkish family.

Ozlem Okutman, Jean Muller, Valerie Skory, Jean Marie Garnier, Angeline Gaucherot, Yoni Baert, Valérie Lamour, Munevver Serdarogullari, Meral Gultomruk, Albrecht Röpke and 11 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of assisted reproduction and genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07402759 (Impact of tdrd9 Gene Mutations in the Therapeutic Response to L-carnitine in Oligoasthenozoospermic Men), which is not on this map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07402759 phase3active not recruitingnot on this mapstarted 2026, after this paper: background citation

Impact of tdrd9 Gene Mutations in the Therapeutic Response to L-carnitine in Oligoasthenozoospermic Men

TypeinterventionalSponsorSouth Valley UniversityRan2026 to 2026Enrolled50ConditionsOligoasthenozoospermia, Male InfertilityArmsL-carnitine
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. A Novel Compound Heterozygous Mutation in TDRD9 Causes Oligozoospermia.Reproductive sciences (Thousand Oaks, Calif.) · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Genetic disorders and male infertility.Reproductive medicine and biology · 2020
    Review
  14. Article
  15. Recent advances in mammalian reproductive biology.Science China. Life sciences · 2020
    Review
  16. Article
  17. Article
  18. Genetic defects in human azoospermia.Basic and clinical andrology · 2019
    Article
  19. From exome analysis in idiopathic azoospermia to the identification of a high-risk subgroup for occult Fanconi anemia.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  20. Genetic evaluation of patients with non-syndromic male infertility.Journal of assisted reproduction and genetics · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 4 countries.

Ozlem OkutmanDépartement Génomique Fonctionnelle et Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Institut National de Santé et de Recherche Médicale (INSERM) U964/Centre National de Recherche Scientifique (CNRS) UMR 7104, Université de Strasbourg, 67404, Illkirch, France.
Jean MullerLaboratoire de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Valerie SkoryDépartement Génomique Fonctionnelle et Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Institut National de Santé et de Recherche Médicale (INSERM) U964/Centre National de Recherche Scientifique (CNRS) UMR 7104, Université de Strasbourg, 67404, Illkirch, France.
Jean Marie GarnierBiologie du développement et cellules souches, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Institut National de Santé et de Recherche Médicale (INSERM) U964/Centre National de Recherche Scientifique (CNRS) UMR 7104, Université de Strasbourg, 67404, Illkirch, France.
Angeline GaucherotMédecine translationnelle et neurogénétique, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Institut National de Santé et de Recherche Médicale (INSERM) U964/Centre National de Recherche Scientifique (CNRS) UMR 7104, Université de Strasbourg, 67404, Illkirch, France.
Yoni BaertBiology of the Testis, Research Laboratory for Reproduction, Genetics and Regenerative Medicine, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090, Brussels, Belgium.
Valérie LamourDépartement Biologie structurale intégrative, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Institut National de Santé et de Recherche Médicale (INSERM) U964/Centre National de Recherche Scientifique (CNRS) UMR 7104, Université de Strasbourg, 67404, Illkirch, France.
Munevver SerdarogullariBahceci Health Group, Sisli, 34365, Istanbul, Turkey.
Meral GultomrukBahceci Health Group, Sisli, 34365, Istanbul, Turkey.
Albrecht RöpkeInstitute of Human Genetics, University of Münster, Münster, Germany.
Sabine KlieschCentre of Reproductive Medicine and Andrology, University of Münster, Münster, Germany.
Viviana HerbepinGenetics Department, CHU-Hôpital Nord, Saint-Etienne, France.
Isabelle AkninReproductive Biology Unit, CHU-Hôpital Nord, Saint-Etienne, France.
Moncef BenkhalifaMédecine de la Reproduction et Cytogénétique Médicale CHU et Faculté de Médecine, Université de Picardie Jules Verne, 80000, Amiens, France.
Marius TeletinDépartement Génomique Fonctionnelle et Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Institut National de Santé et de Recherche Médicale (INSERM) U964/Centre National de Recherche Scientifique (CNRS) UMR 7104, Université de Strasbourg, 67404, Illkirch, France.
Emre BakirciogluUnimed Center, Sisli, 34365, Istanbul, Turkey.
Ellen GoossensBiology of the Testis, Research Laboratory for Reproduction, Genetics and Regenerative Medicine, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090, Brussels, Belgium.
Nicolas Charlet-BerguerandMédecine translationnelle et neurogénétique, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Institut National de Santé et de Recherche Médicale (INSERM) U964/Centre National de Recherche Scientifique (CNRS) UMR 7104, Université de Strasbourg, 67404, Illkirch, France.
Mustafa BahceciBahceci Health Group, Sisli, 34365, Istanbul, Turkey.
Frank TüttelmannInstitute of Human Genetics, University of Münster, Münster, Germany.
STéphane VivilleDépartement Génomique Fonctionnelle et Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Institut National de Santé et de Recherche Médicale (INSERM) U964/Centre National de Recherche Scientifique (CNRS) UMR 7104, Université de Strasbourg, 67404, Illkirch, France. stephane.viville@unistra.fr.
Centre National de la Recherche Scientifique · FRIstanbul Florence Nightingale Hospital · TRUniversity of Münster · DEHôpital Nord · FRUniversité de Strasbourg · FRVrije Universiteit Brussel · BEInserm · FRInstitut de génétique et de biologie moléculaire et cellulaire · FRPérinatalité & Risques Toxiques · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this study was to identify mutations that cause non-syndromic male infertility using whole exome sequencing of family cases.

methodsWe recruited a consanguineous Turkish family comprising nine siblings with male triplets; two of the triplets were infertile as well as one younger infertile brother. Whole exome sequencing (WES) performed on two azoospermic brothers identified a mutation in the melanoma antigen family B4 (MAGEB4) gene which was confirmed via Sanger sequencing and then screened for on control groups and unrelated infertile subjects. The effect of the mutation on messenger RNA (mRNA) and protein levels was tested after in vitro cell transfection. Structural features of MAGEB4 were predicted throughout the conserved MAGE domain.

resultsThe novel single-base substitution (c.1041A>T) in the X-linked MAGEB4 gene was identified as a no-stop mutation. The mutation is predicted to add 24 amino acids to the C-terminus of MAGEB4. Our functional studies were unable to detect any effect either on mRNA stability, intracellular localization of the protein, or the ability to homodimerize/heterodimerize with other MAGE proteins. We thus hypothesize that these additional amino acids may affect the proper protein interactions with MAGEB4 partners.

conclusionThe whole exome analysis of a consanguineous Turkish family revealed MAGEB4 as a possible new X-linked cause of inherited male infertility. This study provides the first clue to the physiological function of a MAGE protein.

Indexed as

AdultAntigens, NeoplasmAzoospermiaChild, PreschoolConsanguinityExome SequencingGene FrequencyGenes, X-LinkedHomozygoteHumansInfertility, MaleMaleMutationNeoplasm ProteinsOligospermiaPedigreeAntigens, NeoplasmMAGEB4 protein, humanNeoplasm ProteinsRNA, MessengerAzoospermiaMAGEB4Male infertilityNo-stop mutationsOligozoospermiaWhole exome sequencing

Identifiers

PMID28401488
PMCPMC5427651
OpenAlexW2606560875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.